The impact of primary tumour origins in patients with advanced oesophageal, oesophago-gastric junction and gastric adenocarcinoma--individual patient data from 1775 patients in four randomised controlled trials.

The impact of primary tumour origins in patients with advanced oesophageal, oesophago-gastric junction and gastric adenocarcinoma--individual patient data from 1775 patients in four randomised controlled trials.

Item
http://www.wikidata.org/entity/Q33402388
Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagusPerioperative chemotherapy versus primary surgery for locoregionally advanced resectable adenocarcinoma of the stomach, gastroesophageal junction and lower esophagusNeoadjuvant chemotherapy followed by surgery versus surgery alone for gastric carcinoma: systematic review and meta-analysis of randomized controlled trialsRandomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trial.Docetaxel and capecitabine for advanced gastric cancer: investigating dose-dependent efficacy in two patient cohorts.Predicting response to treatment in gastroesophageal junction adenocarcinomas: combining clinical, imaging, and molecular biomarkers.The '-omics' revolution and oesophageal adenocarcinoma.Characteristics, therapy and outcome in an unselected and prospectively registered cohort of patients with gastro-oesophageal cancer.Comparison of advanced adenocarcinomas of esophagogastric junction and distal stomach in Japanese patients.Impact of tumour histological subtype on chemotherapy outcome in advanced oesophageal cancer.Palliative chemotherapy and targeted therapies for esophageal and gastroesophageal junction cancer.Treatment for unresectable or metastatic oesophageal cancer: current evidence and trends.HER2 positivity in gastric and esophageal adenocarcinoma: clinicopathological analysis and comparison.
P2860

The impact of primary tumour origins in patients with advanced oesophageal, oesophago-gastric junction and gastric adenocarcinoma--individual patient data from 1775 patients in four randomised controlled trials.

Item
http://www.wikidata.org/entity/Q33402388
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The impact of primary tumour o ...... randomised controlled trials.
@ast
The impact of primary tumour o ...... randomised controlled trials.
@en
type
label
The impact of primary tumour o ...... randomised controlled trials.
@ast
The impact of primary tumour o ...... randomised controlled trials.
@en
prefLabel
The impact of primary tumour o ...... randomised controlled trials.
@ast
The impact of primary tumour o ...... randomised controlled trials.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
The impact of primary tumour o ...... randomised controlled trials.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921